Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcellx (ACLX) Liabilities and Shareholders Equity (2022 - 2025)

Arcellx has reported Liabilities and Shareholders Equity over the past 4 years, most recently at $604.0 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 15.09% year-over-year to $604.0 million; the TTM value through Dec 2025 reached $2.5 billion, down 15.49%, while the annual FY2025 figure was $604.0 million, 15.09% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $604.0 million at Arcellx, down from $655.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $825.1 million in Q4 2023 and troughed at $313.8 million in Q4 2022.
  • A 4-year average of $655.2 million and a median of $648.1 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 162.93% in 2023 and later fell 16.88% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $313.8 million in 2022, then surged by 162.93% to $825.1 million in 2023, then decreased by 13.79% to $711.3 million in 2024, then decreased by 15.09% to $604.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ACLX at $604.0 million in Q4 2025, $655.9 million in Q3 2025, and $619.1 million in Q2 2025.